Bill
Bill > H1016
summary
Introduced
01/22/2019
01/22/2019
In Committee
01/22/2019
01/22/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.
AI Summary
This bill establishes a special commission to investigate the use of maximum allowable costs (MAC) lists, which are utilized by payers and pharmaceutical benefit managers (PBMs) to determine the maximum amount that a health plan will pay for various prescription drugs. The commission will review current practices surrounding the determination and use of MAC lists, industry-wide standardization for their development and use, and transparency in these processes. The commission will consist of 10 members, including representatives from the state government, healthcare industry, and advocacy groups. The commission is required to submit a report with its findings and any legislative recommendations to the relevant legislative committees within 180 days of the bill's passage.
Committee Categories
Business and Industry
Sponsors (12)
Angelo D'Emilia (R),
Paul Frost (R),
Susan Gifford (R),
Bradford Hill (R),
Steven Howitt (R),
Randy Hunt (R),
Brad Jones (R),
Hannah Kane (R),
Elizabeth Poirier (R),
Todd Smola (R),
Mike Soter (R),
Bruce Tarr (R),
Last Action
Accompanied a study order, see H5160 (on 12/01/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/H1016 |
| Bill | https://malegislature.gov/Bills/191/H1016.pdf |
Loading...